Metabolic health plays larger role than weight gain in pregnancy outcomes
August 28, 2025 / metabolic health / gestational diabetes / pregnancy outcomes / maternal obesity / prenatal interventions
Pregnancy outcomes are more influenced by metabolic health than weight gain alone. Women with metabolically unhealthy obesity faced higher gestational diabetes risk and adverse infant outcomes, despite gaining less weight, underscoring the need for early metabolic interventions over weight-focused strategies.
Impact of Metabolic Surgery on Obesity Outcomes and Framingham Risk Score in Iranian Diabetic Patients: A Short- and Long-Term Follow-Up Study
August 29, 2025 / metabolic surgery / type 2 diabetes / cardiovascular risk / obesity treatment / Framingham score
Metabolic surgery significantly improved weight, blood pressure, lipid levels, and Framingham Risk Scores in Iranian patients with type 2 diabetes. The procedures also achieved high remission rates for diabetes, hypertension, and hyperlipidemia, demonstrating both short- and long-term cardiovascular and metabolic benefits.
Metabolic Syndrome Tied to Increased Risk for Parkinson’s Disease
August 29, 2025 / metabolic syndrome / Parkinson’s disease / genetic risk / neurodegenerative disorders / brain health
A 15-year study of 400,000 individuals found that metabolic syndrome significantly increases the risk of Parkinson’s disease, especially in genetically predisposed individuals. The findings highlight metabolic health as a modifiable risk factor for neurodegeneration.
Researchers discover new microprotein that controls metabolic health in mouse fat cells
Aug 30, 2025 / microprotein / mitochondrial health / metabolic stress / obesity therapy / brown fat
Salk researchers identified a novel microprotein, SLC35A4-MP, that preserves mitochondrial structure and regulates metabolic stress in mouse fat cells. This discovery could lead to new treatments for obesity, aging, and mitochondrial disorders.
MedDiet Plus Energy Reduction, Physical Activity Cuts Incidence of Type 2 Diabetes
August 29, 2024 / Mediterranean diet / type 2 diabetes / metabolic syndrome / weight loss / physical activity
A six-year study found that combining an energy-reduced Mediterranean diet with physical activity significantly lowered type 2 diabetes risk in overweight individuals with metabolic syndrome, reducing incidence by 31% compared to the Mediterranean diet alone.
Ultra-processed foods linked to decline in fertility, metabolic health
September 1, 2025 / ultra-processed foods / male fertility / metabolic health / sperm motility / hormone disruption
A randomized controlled trial found that ultra-processed food consumption significantly impaired male reproductive health—lowering sperm motility and altering sex hormones—while also negatively impacting metabolic health, independent of calorie intake.
First enzyme-targeting drug reverses damage in metabolic fatty liver disease
August 27, 2025 / MASH treatment / fatty liver disease / DGAT2 inhibitor / liver inflammation / metabolic health
UC San Diego researchers found that ION224, an investigational drug targeting the DGAT2 enzyme, significantly improves liver health in MASH patients by reducing fat accumulation and inflammation—marking the first enzyme-targeting therapy to reverse liver damage without serious side effects.
What you should know about metabolism, according to a nutrition scientist
August 6, 2025 / metabolism myths / weight loss science / metabolic rate / obesity research / aging and metabolism
Nutrition scientist Dr. Kevin Hall dispels common metabolism myths, emphasizing it’s not a simple lever for weight loss. Metabolism remains stable through most of life and isn’t slower in obesity—highlighting its complex, essential role beyond calorie burning.
Novo Nordisk Partners with Replicate Bioscience for RNA-Based Treatments
August 29, 2025 / RNA therapy / obesity treatment / type 2 diabetes / Novo Nordisk / cardiometabolic disease
Novo Nordisk partnered with Replicate Bioscience to develop self-replicating RNA therapies for obesity, type 2 diabetes, and cardiometabolic diseases, aiming for longer-lasting treatments. The deal includes up to $550 million in milestone payments and bolsters Novo’s RNA innovation strategy.
Overweight patients have better survival rates after surgery
August 26, 2024 / BMI / surgery survival / elderly patients / obesity paradox / postoperative outcomes
Overweight adults aged 65+ had significantly lower 30-day mortality after major elective surgery compared to normal or underweight peers, suggesting current BMI-based surgical guidelines may need revision for older patients, according to UCLA research published in JAMA Network Open.
Intermittent fasting may harm heart health, warns major new study
August 26, 2025 / intermittent fasting / heart health / cardiovascular mortality / metabolic risk / eating window
A major study links 8-hour intermittent fasting to a 135% increased risk of cardiovascular death compared to 12–14 hour eating windows, raising concerns about its long-term impact on heart health, metabolism, and hormonal balance.
For young Indian women, BMI not an accurate tool to indicate obesity, says SSKM study; 50% with ‘normal’ show PCOS risk
August 25, 2025 / BMI accuracy / Indian women / PCOS risk / metabolic dysfunction / obesity assessment
A new SSKM study reveals that BMI may not accurately reflect obesity risk in young Indian women, with 50% of women having normal BMI showing high body fat and increased PCOS risk, urging a reassessment of obesity markers.
Metabolic health plays larger role than weight gain in pregnancy outcomes
August 28, 2025 / gestational diabetes / metabolic health / pregnancy outcomes / maternal obesity / prenatal risk
Metabolic health, more than weight gain alone, significantly impacts pregnancy outcomes. Women with metabolically unhealthy obesity had higher rates of gestational diabetes and infants with more body fat, despite gaining less weight, highlighting the importance of metabolic assessments during pregnancy.
A pill to change gut microbiome key to fight obesity, related heart disease & diabetes risk
August 30, 2025 / gut microbiome / metabolic syndrome / obesity treatment / diabetes prevention / heart disease
A single capsule of healthy gut bacteria significantly reduced metabolic syndrome risk in obese adolescents for up to four years, without affecting weight. This gut microbiome therapy may help prevent heart disease, stroke, and type 2 diabetes.
Oligodendrocyte GIPR Signaling Increases Weight-Loss Effect of GLP-1 Receptor Agonism
August 28, 2025 / GIPR signaling / GLP-1 agonists / obesity treatment / brain access / oligodendrocytes
GIPR signaling in oligodendrocytes enhances brain access and weight-loss efficacy of GLP-1 receptor agonists. This mechanism is crucial for the synergistic effects of dual incretin therapies in obesity treatment, highlighting a novel role for brain support cells.
Novo Nordisk Turns to Self-Replicating RNA Startup to Discover New Metabolic Medicines
August 28, 2025 / self-replicating RNA / metabolic medicine / type 2 diabetes / obesity treatment / Novo Nordisk
Cornell Scientists Unlock the Secret to Age-Defying Weight Control
Fat ‘traffic controller’ protein is a new target for weight loss
August 28, 2025 / CHP1 protein / fat metabolism / obesity treatment / type 2 diabetes / lipid regulation
UNSW researchers identified CHP1 as a key protein regulating fat production and distribution in cells. By controlling enzymes involved in lipid formation, CHP1 offers a promising new target for treating obesity, type 2 diabetes, and other metabolic disorders.
Obesity Guidelines in Focus: Defining Disease and Clinical Boundaries
Dr. Beverly Tchang contrasts Canadian clinical obesity guidelines with The Lancet Commission report, highlighting their differing goals: practical treatment guidance vs. redefining obesity. The discussion raises critical questions about when excess adiposity becomes a treatable medical disease.
Obese teens given healthy gut bacteria show lasting drop in diabetes risk
August 28, 2025 / obese teens / gut microbiome / metabolic syndrome / diabetes prevention / probiotic therapy
A single fecal microbiota transplantation in obese teens significantly reduced long-term risk of metabolic syndrome, a major precursor to diabetes and heart disease. Healthy gut bacteria persisted for years, supporting future probiotic therapies targeting metabolic health.